Source comparison
Metabolic Endpoints MOTS-c Replicates vs What It Misses
AMPK pathway MOTS-c exercise mimetics research demonstrates replication of several core training adaptations, but not all exercise benefits transfer. A 2020 study in Nature Communications showed that MOTS-c administration (15 mg/kg intraperitoneally three time
This comparison does not assign a generated winner or score.
- AMPK pathway MOTS-c exercise mimetics research demonstrates replication of several core training adaptations, but not all exercise benefits transfer. A 2020 study in Nature Communications showed that MOTS-c administration (15 mg/kg intraperitoneally three times weekly for eight weeks) in high-fat diet-fed mice improved glucose tolerance by 62%, reduced fasting insulin by 48%, and increased running endurance capacity by 32%.
- What MOTS-c replicates: insulin-independent glucose uptake via GLUT4 translocation, mitochondrial density increases in skeletal muscle (measured via citrate synthase activity and mtDNA copy number), enhanced fatty acid oxidation rates, and improved lactate clearance during exertion.
- What MOTS-c does NOT replicate: mechanical loading adaptations (bone density, tendon stiffness, myofibrillar hypertrophy driven by mTOR), neuromuscular coordination improvements, VO2max ceiling increases beyond mitochondrial capacity, and the psychological-neurological benefits of voluntary movement. MOTS-c activates the metabolic arm of training adaptation. It doesn't replace the mechanical, cardiovascular, or neurological arms.
- For researchers working with populations where exercise intervention is contraindicated. Severe obesity models, sarcopenia studies, metabolic disease states where physical capacity is too compromised. AMPK pathway MOTS-c exercise mimetics provide metabolic stimulus independent of physical ability. Real Peptides' research-grade MOTS-c is synthesised with exact amino-acid sequencing verified via mass spectrometry, ensuring experimental reproducibility.